Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin’s Lymphoma
Ontology highlight
ABSTRACT: RATIONALE: Interferon alfa may interfere with the growth of the cancer cells and slow the growth of non-Hodgkin’s lymphoma.
PURPOSE: Phase II trial to study the effectiveness of interferon alfa-2b in treating patients who have advanced low-grade non-Hodgkin’s lymphoma.
DISEASE(S): Small Intestine Cancer,Lymphoma, Non-hodgkin,Lymphoma,Intestinal Neoplasms
PROVIDER: 2005102 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA